Clinical Trial Update: Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating pemetrexed for pancreatic cancer that is unresectable or metastatic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED